U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033533) titled 'Allopurinol and Pathogenesis of Cirrhosis' on June 14.
Brief Summary: Hepatic decompensation is a common healthcare issue
. This study was conducted to investigate how allopurinol can interfere with the pathological mechanisms of HD.
Study Start Date: June 01, 2023
Study Type: INTERVENTIONAL
Condition:
Cirrhoses, Liver
Intervention:
DRUG: Allopurinol Tablet
allopurinol 300
DRUG: Placebo
placebo tablet
Recruitment Status: COMPLETED
Sponsor: Tanta University
Information provided by (Responsible Party): Khadija Ahmed Mhrose Glal, Tanta University
Published by HT Digital Content Services with permission from Health Daily D...